These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7650220)
1. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. Burris JF J Clin Pharmacol; 1995 Apr; 35(4):337-42. PubMed ID: 7650220 [TBL] [Abstract][Full Text] [Related]
2. ACE inhibitors: review of four new agents. Binder SB Am Fam Physician; 1993 Oct; 48(5):851-7. PubMed ID: 8213415 [TBL] [Abstract][Full Text] [Related]
3. Modulation of acute transient exercise-induced hypertension after oral administration of four angiotensin-converting enzyme inhibitors in normotensive horses. Muñoz A; Esgueva M; Gómez-Díez M; Serrano-Caballero JM; Castejón-Riber C; Serrano-Rodríguez JM Vet J; 2016 Feb; 208():33-7. PubMed ID: 26626097 [TBL] [Abstract][Full Text] [Related]
5. ACE inhibitors as initial therapy for hypertension. Schoenberger JA Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415 [TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry. Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA; Trials; 2015 Dec; 16():581. PubMed ID: 26686682 [TBL] [Abstract][Full Text] [Related]
7. Newer ACE inhibitors. A look at the future. Salvetti A Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997 [TBL] [Abstract][Full Text] [Related]
8. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Scheen AJ Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153 [TBL] [Abstract][Full Text] [Related]
9. The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure. Frank GJ Cardiology; 1989; 76 Suppl 2():56-67. PubMed ID: 2670222 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
11. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. Frishman WH; Greenberg S Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure. Sedman AJ; Posvar E Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762 [TBL] [Abstract][Full Text] [Related]
18. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. Materson BJ Am J Cardiol; 1992 Apr; 69(10):46C-53C. PubMed ID: 1546639 [TBL] [Abstract][Full Text] [Related]
19. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders. Culy CR; Jarvis B Drugs; 2002; 62(2):339-85. PubMed ID: 11817979 [TBL] [Abstract][Full Text] [Related]
20. [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings]. Lebedev AV; Kukushkin SK; Manoshkina EM; Shamarin VM; Deev AD Kardiologiia; 2003; 43(3):71-2. PubMed ID: 12913982 [No Abstract] [Full Text] [Related] [Next] [New Search]